HALiXPEDITE: Transforming Biologics Therapy Development Programs with Seamless R&D to GMP Integration

HALIX is featured in Business Focus Magazine

Rocketvax and HALIX Collaborate to Advance the VIRUFLEX Platform and Next-Generation Nasal COVID-19 Vaccine

HALIX Appoints Dr. Lutz Hilbrich as New Chief Executive Officer

HALIX Part of Leading Innovator Consortium for 2024 MacRobert Award

HALIX Appoints Richard van Rijnsoever as Vice President of Business Development and Project Management

Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.

Update On HALIX’s Commercial Manufacture Of COVID-19 Vaccine

HALIX facility approved for AstraZeneca’s COVID-19 vaccine active substance manufacturing

HALIX’s Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine